References
- Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendra, and K. Palucka (2000) Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811. https://doi.org/10.1146/annurev.immunol.18.1.767
- Jung, N. C., H. J. Kim, M. S. Kang, J. H. Lee, J. Y. Song, H. G. Seo, Y. S. Bae, and D. S. Lim (2012) Photodynamic therapymediated DC immunotherapy is highly effective for the inhibition of established solid tumors. Cancer Lett. 324: 58-65. https://doi.org/10.1016/j.canlet.2012.04.024
- Lim, D. S., J. H. Kim, D. S. Lee, C. H. Yoon, and Y. S. Bae (2007) DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors. Cancer Immunol. Immunother. 56: 1817-1829. https://doi.org/10.1007/s00262-007-0325-0
- Zahradova, L., K. Mollova, D. Ocadlikova, L. Kovarova, Z. Adam, M. Krejci, L. Pour, A. Krivanova, V. Sandecka, and R. Hajek (2012) Efficacy and safety of Id-protein-loaded dendritic cell vaccine in patients with multiple myeloma-phase Ii study results. Neoplasma. 59: 440-449. https://doi.org/10.4149/neo_2012_057
- Koski, G. K., U. Koldovsky, S. Xu, R. Mick, A. Sharma, E. Fitzpatrick, S. Weinstein, H. Nisenbaum, B. L. Levine, K. Fox, P. Zhang, and B. J. Czerniecki (2012) A novel dendritic cellbased immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in woman with early breast cancer. J. Immunother. 35: 54-65. https://doi.org/10.1097/CJI.0b013e318235f512
- Legler, D. F., P. Krause, E. Scandella, E. Singer, and M. Groettrup (2006) Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 176: 966-973. https://doi.org/10.4049/jimmunol.176.2.966
- Kalinski, P. (2012) Regulation of immune responses by prostaglandin E2. J. Immunol. 188: 21-28. https://doi.org/10.4049/jimmunol.1101029
- Jeong, J. G. (2004) General perspective for molecular nuclear imaging. The Korean Society of Nuclear Medicine 38: 111-114.
- Christian, N. A., F. Benencia, M. C. Milone, G. Li, P. R. Frail, M. J. Therien, G. Coukos, and D. A. Hammer (2009) In vivo dendritic cell tracking using fluorescence lifetime imaging and nearinfrared- emissive polymersomes. Mol. Imaging Biol. 11: 167-177. https://doi.org/10.1007/s11307-008-0184-x
- Ahrdns, E. T., R. Flores, H. Xu, and P. A. Morel (2005) In vivo imaging platform for tracking immunotherapeutic cells. Nat. Biotechnol. 23: 983-987. https://doi.org/10.1038/nbt1121
- Noh, Y. W., Y. T. Lim, and B. H. Chung (2008) Noninvasive imaging of dendritic cell migration into lymph nodes using near-infrared fluorescent seminonductor nanocrystals. FASEB 22: 3908-3918. https://doi.org/10.1096/fj.08-112896
- Kim, S., Y. T. Lim, E. G. Soltesz, A. M. De Grand, J. Lee, A. Nakayama, J. A. Parker, T. Mihaljevic, R. G. Laurence, D. M. Dor, L. H. Cohn, M. G. Bawendi, and J. V. Frangioni (2003) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22: 93-97.
- Ntziachristos, V., C. Bremer, and R. Weissleder (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur. Radiol. 13: 195-208.
- Shah, K., E. Bureau, and D. E. Kim (2005) Glioma therapy and real-time imaging of neural precursor cell migration and tumor regression. Ann. Neurol. 57: 34-41. https://doi.org/10.1002/ana.20306
- Giepmans, B. N., S. R. Adams, and M. H. Ellisman (2006) The fluorescent tool-box for assessing protein location and function. Science 312: 217-224. https://doi.org/10.1126/science.1124618
- Sutton, E. J., T. D. Henning, B. J. Pichler, C. Bremer, and H. E. Daldrup-Link (2008) Cell tracking with optical imaging. Eur. Radiol. 18: 2021-2032. https://doi.org/10.1007/s00330-008-0984-z
- Julius, M. H., E. Simpson, and L. A. Herzenberg (1973) A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur. J. Immunol. 10: 645-649.